While computed tomography (CT) has revolutionized medical imaging, it has also required much higher doses of ionizing radiation than was previously used in traditional X-ray imaging. In recent years, vendors have turned their attention to developing technology to drastically reduce dose.
Portable Ultrasounds
Portable Ultrasound Machines
Toshiba Portable Ultrasound Machines
Portable Ultrasound
Portable Ultrasound System

With the advent of handheld ultrasound systems, the idea of a doctor in the emergency department (ED) with an ultrasound clipped to his keyboard is not too far-fetched. We are not there yet, but competition is growing in the market. While there are signs the market has begun to mature, there also are signs it could expand into new territory.

AxoTrack sterile procedure kit

Soma Access Systems LLC received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its AxoTrack sterile procedure kit. Portable ultrasound maker Terason also recently received 510(k) clearance for the first ultrasound probe to be equipped with Soma’s patented AxoTrack virtual needle technology.


It seems a picture is worth more than a thousand words for people who see evidence of coronary artery disease, the most common type of heart disease in men and women. Simply seeing a build-up of calcium in the walls of arteries appears to prompt patients to better adhere to both statin therapy and recommendations for weight loss, according to research presented at the American College of Cardiology’s 61st Annual Scientific Session in Chicago.

Interventional radiology treatments re-establish blood flow in people with chronic deep vein thrombosis (DVT), reducing disabling symptoms and improving the quality of life for those afflicted with post-thrombotic syndrome—an under-recognized but frequent long-term complication of DVT. Researchers presented these findings during March's DVT Awareness Month at the Society of Interventional Radiology's (SIR) 37th Annual Scientific Meeting in San Francisco.

April 2, 2012 — Two new studies demonstrate the cosmetic and dosimetric advantages of the SAVI breast brachytherapy applicator for treatment of early-stage breast cancer. The studies were presented as scientific posters at national medical conferences and were drawn from 12 centers participating in the SAVI Collaborative Research Group.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now